UBS Group AG - NEUROPACE INC ownership

NEUROPACE INC's ticker is NPCE and the CUSIP is 641288105. A total of 29 filers reported holding NEUROPACE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
UBS Group AG ownership history of NEUROPACE INC
ValueSharesWeighting
Q3 2023$535
-95.6%
55
-97.9%
0.00%
Q1 2023$12,171
+426.4%
2,623
+69.0%
0.00%
Q4 2022$2,312
-71.1%
1,552
-28.6%
0.00%
Q3 2022$8,000
+700.0%
2,173
+2051.5%
0.00%
Q1 2022$1,000
-97.4%
101
-97.3%
0.00%
Q4 2021$38,000
-37.7%
3,703
+44.5%
0.00%
Q2 2021$61,0002,5630.00%
Other shareholders
NEUROPACE INC shareholders Q3 2022
NameSharesValueWeighting ↓
KCK LTD. 5,621,111$46,149,00045.03%
Revelation Capital Management, LLC 380,705$3,126,00011.43%
Soleus Capital Management, L.P. 2,324,003$19,080,0002.46%
Orbimed Advisors 4,012,281$32,941,0000.53%
Nantahala Capital Management 485,303$3,984,0000.18%
Bellevue Group AG 507,930$4,170,0000.05%
KORNITZER CAPITAL MANAGEMENT INC /KS 199,919$1,641,0000.03%
Point72 Asset Management, L.P. 209,176$1,717,0000.01%
AMERICAN CENTURY COMPANIES INC 534,664$4,390,0000.00%
MILLENNIUM MANAGEMENT LLC 423,028$3,473,0000.00%
View complete list of NEUROPACE INC shareholders